Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONI heparin dose study during aneurysm embolization
2026-526530-13-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of heparin in brain aneurysm (IA) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Presence of at least one recent ischemic lesion on diffusion-weighted MRI. Planned start Sep 2026; status: authorised.
02
Drugs
heparin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on 2026-526530-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526530-13-00.